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Oxytocin evokes a pulsatile PGE2 
release from ileum mucosa and 
is required for repair of intestinal 
epithelium after injury
Dawei Chen*, Junhan Zhao*, Haoyi Wang, Ning An, Yuping Zhou, Jiahui Fan, Junwen Luo, 
Wenlong Su, Chuanyong Liu & Jingxin Li
We measured the short-circuit current (Isc) in rat ileum mucosa to identify the effect of oxytocin 
(OT) on mucosal secretion in small intestine. We identified a COX-2-derived pulsatile PGE2 release 
triggered by OT in rat ileum mucosa. OT receptors (OTR) are expressed in intestine crypt epithelial 
cells. Notably, OT evoked a dynamic change of [Ca2+]i in ileum crypts, which was responsible for this 
pulsatile release of PGE2. OT ameliorated 5-FU-, radiation- or DSS- induced injury in vivo, including 
the improvement of weight loss, reduced villus height and impaired survival of crypt transit-
amplifying cells as well as crypt. Moreover, these protective effects of OT against intestinal injury 
were eliminated by coadministration of a selective inhibitor of PGE2, AH6809. Our findings strongly 
suggest that OT, a novel and important regulator of intestine mucosa barrier, is required for repair of 
intestinal epithelium after injury. Considering that OT is an FDA-approved drug, this work reveals a 
potential novel and safe way to combat or prevent chemo-radiotherapy induced intestine injury or to 
treat IBD.
The intestinal epithelium is the most vigorously self-renewing tissue of adult mammals. The four dif-
ferentiated cell types that reside within the epithelium-goblet cells, enteroendocrine cells, paneth cells, 
and enterocytes. Proliferative cells reside in the crypts. The crypts harbor stem cells and their progeny, 
transit-amplifying cells (TACs). TACs spend approximately two days in the crypt, in which they divide 
4–5 times before they terminally differentiate into the specialized intestinal epithelial cell types. Oxytocin 
(OT) is best known as a hormone produced in the paraventricular nucleus of the hypothalamus that 
stimulates OT receptors (OTR) to initiate milk ejection reflex and parturition1–5. OT/OTR, however, 
also participate in social behaviours, promoting trust and bonding6–9. In addition, OT has been shown 
to facilitate in vitro differentiation of mesenchymal stem cells towards cardiomyogenesis and osteogene-
sis10,11 and enhanced muscle stem cell activation/proliferation12. OT and OTR expression also has been 
demonstrated in bowel13–15. Enteric OT, like that of brain, is restricted to neurons; however, enteric OTRs 
are not exclusively neuronal. Enterocytes also express OTRs14. Intriguingly, OTRs is restricted to crypts, 
especially at crypt-villus boundaries14. Welch MG et al. recently demonstrated that OT/OTR signaling 
plays an important role in regulating the proliferation of crypt cells and mucosal permeability, and pro-
tecting from inflammation16.
Here, using short-circuit current (Isc) as dynamic biosensors of prostaglandins (PGs) release, we found 
that OT evokes a COX-2 dependent pulsatile release of prostaglandin E2(PGE2) by triggering [Ca2+]i 
oscillations in ileum mucosa, and demonstrated that OT/PGE2 signalling pathway is required for intes-
tinal epithelium regeneration. Importantly, we showed that systemic OT delivery alleviates chemo- and 
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radiation-induced intestinal epithelium injury by improving TACs proliferation function and prolongs 
overall survival in mice, while pharmacologic attenuation of PGE2 signalling with a selective antagonist 
blocks the OT-induced protect effects. Our results suggest that this OT-evoked finely tuned release of 
PGE2 from intestinal epithelium could become a potential treatment to enhance host tolerance to aggres-
sive chemoradiotherapy.
Results
OT evoked a continuous and pulsatile response in Isc in rat ileum. The effect of OT on transep-
ithelial ion transport was investigated using the Ussing chamber technique. The addition of OT (10−6 M) 
to serosal bathing solution evoked a pulsatile response in Isc in rat ileum, however, the mucosal addition 
of OT did not affect basal electrical activity (Fig.  1A). The frequency and amplititude of OT-evoked 
pulsatile response was 9.2 ± 2.1 mHz, 3.3 ± 1.2 pA, respectively (Fig.  1B). This OT-evoked response is 
in a dose-dependent manner (Fig. 1C,D), which was sustained for at least 2 hours (Fig. 1E). To further 
investigate the underlying mechanism of this OT-induced Isc response in rat ileum, atosiban, a specific 
blocker of OTR, was added to the bathing solution 15 min before the application of OT. Atosiban totally 
blocked the OT-evoked pulsatile response in Isc (Fig. 1F). To investigate the involvement of the enteric 
nervous system ( ENS) in the serosal OT-induced Isc response. TTX (10−6M), a Na+ channel blocker, 
was added to the serosal bathing solution 15 min before the addition of OT. Unexpectedly, TTX did not 
affect the OT-evoked pulsatile response in Isc (Fig. 1G,H).
COX-2 dependent PGE2 release is responsible for the OT-evoked pulsatile response In Isc. 
Next, we investigated the effect of a non-selective cyclooxygenase (COX) inhibitors (indomethacin and 
naproxen) in OT-evoked pulsatile response In Isc. The results showed that either non-selective COX 
Figure 1. OT evoked a continuous and pulsatile response in Isc in rat ileum. (A) Serosal but not mucosal 
administration of OT evoked a pulsatile response in Isc in rat ileum, which has a 9.2 ± 2.1 mHz in frequency 
and 3.3 ± 1.2pA in amplititude (B, n = 7). The OT-evoked response was in dose-dependent manner (C-D, 
n = 4), which was sustained for at least 2 hours (Fig. 1E). Atosiban, but not TTX totally blocked the OT-
evoked pulsatile response (F-H, n = 5).
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inhibitor indomethacin or naproxen (Fig. 2A,E) completely blocked the OT-evoked pulsatile response in 
Isc in rat ileum. To further determine the role of COX-1 or COX-2 in OT-evoked pulsatile response, a 
selective COX-1 inhibitor (SC560) or selective COX-2 inhibitors (NS398 and Celecoxib) were used. The 
selective COX-2 inhibitor NS398 (Fig.  2C,E) or Celecoxib totally blocked the OT-stimulated pulsatile 
response, but the selective COX-1 inhibitor SC560 (Fig. 2B,E) did not. ELISA results demonstrated that 
in the presence of OT, PGE2 was release from cultured rat ileum mucosa (Fig. 2F, left lane), which can be 
blocked by NS398, but not SC560 (Fig. 2F, right lane). To further confirm PGE2 involves in OT-evoked 
pulsatile response in rat ileum mucosa, the EP2 antagonist, AH6809 was used. Unsurprisingly, it com-
pletely blocked the OT-evoked pulsatile response (Fig. 2D-E). Moreover, the solvent DMSO has no effect 
on OT-stimulated pulsatile response (Fig. 2E). These findings suggest that OT-evoked pulsatile response 
in Isc is mediated through PGE2 produced by COX-2.
[Ca2+]i oscillations in ileum crypt cells involve OT-evoked pulsatile PGE2 release. To inves-
tigate whether Ca2+ involve in OT-evoked pulsatile PGE2 release, first, thapsigargin or nicadipine was 
used. Depletion of intracellular Ca2+ stores with thapsigargin eliminatedthe OT-evoked pulsatile response 
in Isc but nicadipine, a L-type Ca2+ channel blocker, did not produce any effect (Fig. 3A–C). Moreover, 
ELISA results further demonstrated that OT-induced PGE2 release was largely inhibited by thapsigargin, 
but not nicadipine (Fig.  3D). Second, we tested the effect of OT on the [Ca2+]i dynamics of epithelial 
cells in mouse ileal crypts. The spatiotemporal dynamics of [Ca2+]i were measured by confocal imaging 
analysis in isolated crypts of mouse. Cells were loaded with the Ca2+ indicator dye fluo-3. Thereafter, OT 
induces an increase in cytosolic Ca2+ of crypt epithelial cells (Fig. 3E). Interestingly, OT-induced [Ca2+]i 
dynamics of crypt epithelial cells have a spontaneous fluctuation pattern (Fig. 3F,G, Supplemental video). 
Taken together, these results hint that [Ca2+]i oscillations of crypt epithelial cells involve OT-evoked 
pulsatile PGE2 release.
OT protects intestinal mucosa by triggering the release of PGE2 from 
chemoradiotherapy-induced intestinal injury. To investigate whether OT protects intestinal epi-
thelium from chemoradiotherapy-induced intestinal injury. First, we used 5-FU injury model as chem-
otherapeutic model (30 mg/kg/d). After 5-FU treatment, body weight, ileum villus height and TACs 
number were significantly deceased (Fig. 4A-C). Administration of OT largely ameliorated 5-FU-induced 
injury either in weight loss and villus height, or TACs number. Moreover, AH 6809, behaved as an EP2 
receptor antagonist, totally inhibited OT-induced protection in 5-FU-induced injury. In order to deter-
mine whether OT improves stem cells’s proliferative ability, we utilized BrdU as label. OT significantly 
increased the number of BrdU+ cells than in 5-FU-treated only group. Furthermore, AH6809 blocked 
OT-induced protection (Fig. 4D).
Second, we determine if OT is radioprotective in the intestine. Ten Gy whole body irradiation (WBI) 
exposure caused edema in the small intestine (Fig.  5A). Moreover, the villus height, the number of 
TACs or surviving crypts per intestinal cross section were also decreased after radiation (Fig.  5B–D). 
Administration of OT (0.1 mg/kg) 24 hours before radiation reduced the edema of the small intestine and 
increased either the villus height or the number of TACs (Fig. 5A–C). Notably, OT treatment increased 
the number of surviving crypts to 1.5-fold (Fig. 5D). To implicate PGE2 as a mediator of OT-induced 
radioprotection, EP2 antagonist AH6809 was used to determine if the radioprotective effects of OT were 
mediated through the induction of PGE2 synthesis. When AH6809 was administered with OT, the pro-
tective effects of OT in small intestine after radiation were lost (Fig. 5A–D).
Together, these findings suggest that the effects of OT as a novel chemo- and radio-protective agent 
are mediated through PGE2.
OT alleviates dextran sulfate sodium (DSS)-induced intestinal injury. The murine DSS coli-
tis model has been widely adopted to induce severe acute, chronic or semi-chronic colitis. After DSS, 
the concentration of OT was significantly decreased in colon from DSS-induced colitis mouse model 
(Fig.  6A) and the weight loss of OT treatment mice was significantly less than that of control mice in 
injury phase, and the gain weight of OT treatment mice was larger than that of control mice during the 
recovery period (Fig.  6B), which was concomitant with OT treatment mice displaying increased villus 
size (Fig. 6C) and elevated histological colitis scores (Fig. 6D–E). The colons from OT treatment mice 
exhibited a significant decrease in injury compared with control colons following DSS treatment charac-
terized by epithelial cell loss, crypt damage, and immune cell infiltration (Fig. 6D).
In addition, a large increase in mucus production were observed in OT treatment mice by PAS stain-
ing (Fig. 6F).
Discussion
OT is a mammalian neurohypophysial hormone, which acts primarily as a neuromodulator in the brain. 
In this study we show that OT evokes a pulsatile release of PGE2 in mouse ileum mucosal epithelium. 
Importantly, OT induced Ca2+ oscillations in ileum crypt is responsible for the pulsatile PGE2 release. 
Moreover, we found that OT is require for crypt cells proliferation, and is chemo-and radio-protective 
in the intestine and that its protective effects are mediated through the induction of PGE2 synthesis.
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Figure 2. COX-2-derived PGE2 is responsible for the OT-evoked pulsatile response In Isc. Non-selective 
COX inhibitor indomethacin or naproxen (A and E) completely blocked the OT-evoked pulsatile response In 
Isc in rat ileum (n = 6). The selective COX-2 inhibitor NS398 (C and E), but not COX-1 inhibitor SC560(B and 
E) totally blocked the OT-stimulated pulsatile response (n = 6). OT evoked a pulsatile PGE2 release in cultured 
rat ileum mucosa, which can be blocked by NS398, but not SC560 (F, n = 6). The EP2 antagonist, AH6809, 
completely blocked the OT-evoked pulsatile response (D,n = 5). *P < 0.05 versus control; #P < 0.05 versus Saline.
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A pulsatile PGE2 release from ileum mucosal epithelium evoked by OT is COX-2- and [Ca2+]i- 
dependent. PGs are known to play a role in ion transport across gastrointestinal epithelia. PGE2 
increases chloride secretion in guinea pig colon17 and porcine small intestine18. In our study, chloride 
secretion was measured as Isc utilizing Ussing chamber methodology. Therefore, the change of Isc can be 
as dynamic biosensors of PGs release from mouse ileum mucosa. The key finding of the present work is 
that OT evokes a release of PGE2 from ileum mucosa. PGs are synthesized through two COX isoforms, 
COX-1 and COX-219. COX-1 is a protein that is constitutively expressed in almost all tissues whereas the 
expression of COX-2 is highly regulated20. Several groups have reported that COX-2 also constitutively 
expressed in numerous tissues, including the kidney21, colon22, central nervous system23 and vascular 
endothelium24. Through the actions of either COX-1 or COX-2 (or both), arachidonic acid is converted 
Figure 3. [Ca2+]i oscillations in ileum crypt cells involve OT-evoked pulsatile PGE2 release. 
Thapsigargin, an intracellular Ca2+ pump blocker, but not nicadipine, a L-type Ca2+ channel blocker 
completely blocked the OT-evoked pulsatile response in Isc (3A-C). Moreover, OT-induced PGE2 release was 
also largely inhibited by thapsigargin, but not nicadipine (3D, n = 5). Confocal Ca2+imaging revealed that 
OT induces a dynamic change in cytosolic Ca2+ of crypt epithelial cells (3E-F). Scale bar: 10 μ m. *P < 0.05.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:11731 | DOi: 10.1038/srep11731
to PGH2, which is then rapidly metabolized by various PG synthases to form PGs such as PGE225. 
PGE2, the most abundant gastrointestinal PG, regulates many of the normal homeostatic functions of the 
gut, including motility and secretion26–30. Here we show that OT-evoked PGE2 release in mouse ileum 
mucosa is COX-2 dependent. Interestingly, OT-evoked release of PGE2 from ileum mucosa is oscillatory. 
Figure 4. OT protects intestinal mucosa through PGE2 in 5-FU induced intestinal injury model.  
(A) The clinical severity of 5-FU-induced injury was tracked with relative weight loss as a surrogate marker 
(B) Effects of exogenous OT on 5-FU-induced intestinal morphology. Ileums from mice were stained with 
H&E, and the relative villus sizes were measured and statistically analyzed. Scale bar: 100 μ m (C) OT 
protects the number and distribution of intestinal TACs after administration of 5-FU. Ileum from mice were 
immunohistochemically stained for Ki67+ cells. The numbers of positive cells were counted in each crypt. 
Scale bar: 50 μ m (D) BrdU+ cells percent in each crypt represents the proliferation of intestinal stem cells. 
Scale bar: 50 μ m. Results represent 30 tissue specimens in each group (n = 5) and the mean ± s.d. of six 
tissue sections per mouse. *P < 0.05; **P < 0.01; ***P < 0.001.
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Previous studies have demonstrated that OT induces [Ca2+]i oscillations in human myometrial cells31 and 
in rat live cell line (Clone 9)32. Interestingly, they found the OT-induced [Ca2+]i oscillations frequency 
was around 10 mHz, similarly to what we found in the present study. In mouse ileal crypts, some neuro-
transmitters can induce [Ca2+]i dynamics of epithelial cells33. Furthermore, cytosolic calcium oscillations 
regulate a pulsatile PG release34.
Our present data demonstrated that OT stimulates relatively low frequency but large- amplititude 
[Ca2+]i oscillations (i.e., ranging from approximately one oscillation every 10 min) in mouse ileum crypt 
cells, in which contains a relatively high frequency but small- amplititude oscillations (i.e., ranging from 
approximately one oscillation every 1 min). The large wave may be attributable to global Ca2+ feedback 
loops and the balance between Ca2+ release/entry and Ca2+ pumps, and the small Ca2+ oscillations 
presumably result from activation of PI-PLC via G protein-linked receptors, which results in sustained 
generation of IP3 and subsequent release of Ca2+ from IP3-sensitive stores in the endoplasmic reticulum 
balanced by the actions of Ca2+ pumps that lower intracellular Ca2+.
Beside ENS, ileum crypt cells, especially at crypt-villus boundaries also expressed OTR14. It may be 
a direct effect of OT on epithelial cells. In the myometrium, OT binds to a specific G protein-coupled 
receptor (GPCR) linked through Gα q/11 to phospholipase Cβ (PLCβ ). Activation of PLCβ results in 
the production of inositol 1, 4, 5-trisphosphate (IP3) and diacylglycerol (DAG)2. IP3 releases Ca2+ from 
Figure 5. OT is radioprotective in small intestine epithelium. (A) Mouse was euthanized and ileum was 
pulled out to show the severity of intestinal edema. (B) Effects of exogenous OT on irradiated intestinal 
morphology. Ileum from mice were stained with H&E, and the relative villus sizes were measured and 
statistically analyzed. Scale bar: 100 μ m (C) OT protects the number and distribution of intestinal TACs after 
irradiation Ileum from mice were immunohistochemically stained for Ki67+ cells. The numbers of positive 
cells were counted in each crypt. Scale bar: 50 μ m (D) Crypt survival after irradiation in mice. Mice received 
10 Gy of total body irradiation and were killed 3.5 days later. All animals received 5-bromo-2-deoxyuridine 
2 h before death to label replicating epithelial cells. Results represent 30 tissue specimens in each group 
(n = 5) and the mean ± s.d. of six tissue sections per mouse. *P < 0.05; **P < 0.01; ***P < 0.001.
www.nature.com/scientificreports/
8Scientific RepoRts | 5:11731 | DOi: 10.1038/srep11731
Figure 6. OT alleviates intestinal inflammation induced by DSS Mice were adminstered of 2.5% DSS for 
7 days as injury phase, and the other groups of mice were treated with 2.5% DSS for 7 days followed by 7 
days of recovery. (A) The concentration of OT was largely decreased in colon from DSS-induced mouse 
model (n = 5). (B) Mice weights were recorded each day and relative weight changed were regarded as 
measurement of injury degree (n = 5) (C) Ileum from mice were stained with H&E, and the relative villus 
sizes were measured and statistically analysed. Scale bar: 100 um (D) Representative images of mice colon 
H&E staining. Scale bar: 50 μ m (E) Clinical colitis scores on the basis of histological sections of mice colon 
(F) PAS staining of colonic sections and the staining pattern on behalf of goblet cells secretion mucus. Scale 
bar: 50 μ m. Results represent 30 tissue specimens in each group (n = 5) and the mean ± s.d. of six tissue 
sections per mouse. *P < 0.05; **P < 0.01; ***P < 0.001.
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intracellular stores. OT induces COX-2 expression mainly by activating PKC and ERK in human myo-
metrial cells35. Intracellular Ca2+ triggers the expression of COX-2 by activating PKC-α and calmodulin 
kinase II (CaMKII) cascades36. Therefore, we hypothesis that OT, released from enteric neuron, evokes 
a PGE2 release via OTR/PKC or ERK/Ca2+ in ileum cryt cells (Fig. 7).
OT involves in the repair after intestine epithelial injury. PGE2 has been reported to be impor-
tant for the regulation of stem cells growth and differentiation37–39. Furthermore, PGE2 increases intesti-
nal crypt stem cells survival40,41. Previous research have shown OTR expression was restricted in crypts 
and concentrated on crypt-villus junction14, and TACs occupied this position primarily42. The crypt is a 
proliferative compartment which is composed of 250–300 cells that are in constant active proliferation; 
it also generates all of the cells required to renew the entire intestinal epithelium in mice in 2–3 days. 
Recent research reveals that Villi and crypts were shorter in OTR knockout mice than in wild-type 
mice and TAC proliferation in OTR knockout mice crypts was deficient16. We also confirmed that OTR 
expressed in TACs, and OT increased the crypt cell proliferation (Supplemental figure1). Using chemo- 
or radio-therapy-induced mouse models of intestinal epithelial injury, we further confirmed that the 
OT is protective by promoting the crypt cells proliferation. Exogenous or endogenous PGE2 have been 
shown to be radioprotective40,43,44 in the intestine. There are 4 known receptors for PGE2 (EP1, EP2, EP3, 
and EP4). Two of these (EP2 and EP4) are expressed in the crypt cells from human colon and inflamed 
small intestine45. Our present study shows that treatment with OT increased total intestinal PGE2 lev-
els 2.5-fold, and AH6809, an EP1/2 antagonist, blocked the OT-evoked protection against chemo- and 
radio-induced injury.
Three pieces of indirect evidence also suggest that PGE2 is the mediator. The first is that PGE2 is 
radioprotective in the intestine44 and AH6809 worsens the chemo- and radio-induced injury; the second 
Figure 7. Proposed mechanisms for OT-evoked PGE2 release in rat ileum mucosa. OT, released from 
enteric neuron, activates PKC and ERK upon binding with its receptors in intestine epithelial cells or other 
cells of the lamina propria, induces the increase of [Ca2+], then triggers the expression of COX-2 and thus 
evokes a PGE2 release.
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is that PGE2 is the most abundant prostaglandin in the intestinal epithelium46; and the third is that PGE2 
is known to modulate stem cell survival41.
PGs are degraded very rapidly and usually act on cells near the cells in which they are produced. The 
simpler and more likely explanation is that PGE2 produced by crypt epithelial cells acts on stem cells to 
induce protection.
This suggests that OT-induced protection may be mediated by PGE2 produced by crypt epithelial 
cells themselves.
Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions with unknown 
pathogenesis. IBD comprised of Crohn’s disease (CD) and ulcerative colitis (UC), are chronic diseases 
characterized by aberrant immune responses to luminal bacteria in genetically susceptible subjects47. 
The colonic epithelium is covered by a continuous mucus layer, which serves as an important barrier 
and prevents colonic bacteria from invading the mucosa and cause inflammation. The mucus layer also 
functions as a shelter that is required to retain a bacterial colonization within the colon and prevents 
the bacteria from constantly being removed by peristalsis. Thus colonic mucus has dual functions, being 
a functional barrier to avoid contact of bacteria to the epithelium and simultaneously enabling bacteria 
persistence within the colon. There is a correlation between decreasing mucus barrier and increasing 
clinical symptoms during onset of colitis48. In our present study, we found OT alleviated DSS-induced 
colitis. Interestingly, OT also increased the mucus production in colon.
In conclusion, our results reveal that OT evoked a pulsatile PGE2 release from intestine mucosa, and 
is responsible for the repair after intestine epithelial injury. There may be therapeutic potential for OT in 
protecting the intestinal epithelium in patients receiving chemotherapy or radiation therapy. Considering 
that OT is an FDA-approved drug, this work reveals a potential novel and safe way to combat or prevent 
chemo-radiotherapy induced intestine injury or to treat IBD.
Methods
Animal models. C57BL6/J mice and Wistar rats were purchased from the Animal Centre, Shandong 
University, China. 6–8 weeks male mice were divided with randomization. In crypt stem cell prolifera-
tion experiment, mice were intraperitoneally injected with normal saline (NS) or OT (1 mg/kg/day) for 
14 days. In 5-fluorouracil (5-FU)-induced intestinal injury model, mice were given 5-FU (30 mg/kg/
day for 5 days for the therapeutic dose). A radiation-induced intestinal injury model was established 
in mice by whole body irradiation (10 Gy total body irradiation using a 6MV-X linear accelerator). For 
DSS-inducedinjurymodel, 2.5% DSS salt (reagent-grade, mol. wt. 36 to 50 kDa; MP Biomedicals) in auto-
claved drinking water was given to mice for 7 days as injury phase, for recovery studies, DSS was admin-
istered for the first 7 days as indicated, and then DSS was removed from the drinking water and mice 
were killed 7 days after the cessation of DSS treatment. One day before chemical treatment or 10 Gy irra-
diation, Mice were injected intraperitoneally normal NS, OT (0.1 mg/kg/day) or OT + AH6809(0.5 mg/
kg/day). Animals were killed after chemical treatment or irradiation, and rapidly dissected, as described 
previously41. The proximal jejunum was fixed before paraffin embedding and immunohistochemical 
analysis. Crypt survival was counted in animals killed 3.5d after irradiation using a modification of the 
microcolony assay49. 2 hours before death, 5-bromodeoxyuridine (BrdU)(120 mg/kg) and 5FU (12 mg/
kg) was injected to each mouse to label S phase cells. The 5 μ m paraffin sections were prepared from 
ileum oriented so that the sections were cut perpendicular to the long axis of the small intestine. The via-
bility of each surviving crypt was confirmed by immunohistochemical detection of BrdU incorporation 
into five or more epithelial cells within each regenerative crypt in at least six intergtal sections. Histologic 
evaluation was performed by two investigators blinded to the animal groups and the inflammation was 
graded as follows: severity of inflammation (0–3: none, slight, moderate, severe), extent of injury (0–3: 
none, mucosal, mucosal and submucosal, transmural), and crypt damage (0–4: none, basal 1/3 damaged, 
basal 2/3 damaged, only surface epithelium intact, entire crypt and epithelium lost).
All experimental procedures were conducted in accordance with the Guidelines for the Care and 
Use of Laboratory Animals of Shandong University, and the study was approved by the Medical Ethics 
Committee for Experimental Animals, Shandong University, China (number ECAESDUSM 2012029).
Isc measurement. Rats, weighting between 200 and 250 g, were used for this study. Animals were 
fasted overnight with free access to water before experiments, and then anesthetized and decapitated. 
Segments of ileum were cut along the mesenteric border, and luminal contents were gently removed. 
Tissues were pinned flat on a Sylgard-lined Petri dish with mucosal surface down, and tissue preparations 
were constructed by using forceps and scissors. To obtain the mucosal-submucosal preparations, the ser-
osa and muscularis were gently stripped away. During preparation, tissues were bathed in ice-cold Krebs 
solution (bathing solution) and continuously oxygenated with a gas mixture of 95%O2 and 5%CO2. 
Krebs solution contained (in mM) 120.6 NaCl, 5.9 KCl, 2.5 CaCl2,1.2 KH2PO4, 1.2 MgCl2, 15.4 NaHCO3 
and 11.5 glucose.
Isc was measured in vitro in Ussing chamber technique. The tissue preparations were mounted 
between the 2 halves of the Ussing chambers (exposed area of 0.50 cm2), equipped with water-jacketed 
gas lifts, and were bathed on both sides with 5 mL Kerbs solution, gassed with 95% O2 and 5% CO2, 
pH adjusted to 7.4, and maintained at 37 °C by circulating the solution through a reservoir during the 
experiments. The tissue was continuously voltage-clamped to zero potential difference by the application 
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of external current, with compensation for fluid resistance. The baseline value of the electrical parame-
ters was determined as the mean over the 3 min immediately prior to drug administration. The tissues 
were allowed to rest for approximately 10 min to stabilize the Isc prior to the addition of drugs. The 
transepithelial potential difference for each preparation was measured with Ag/AgCl reference electrodes 
(P2020S; Physiologic Instruments, San Diego, Calif) connected to a preamplifier that was, in turn, con-
nected to a voltage clamp amplifier (VCC MC4; Physiologic Instruments, San Diego, Calif). To check 
tissue availability, tissues were stimulated by carbachol (CCh). Changes in Isc were measured. Each drug 
was dissolved in distilled water or DMSO solution for stock solution and added to the bath to provide 
the desired molar concentration. Thapsigargin (1 μ M) and nicadipine (1 μ M) were used to investigate 
whether Ca2+ involved in OT-evoked Isc changes.
Immunofluorescent and immunohistochemistry. The ileum was open longitudinally and flushed 
by cold PBS until most of the luminal content were clear. The tissues were fixed in 4% paraformaldehyde 
overnight and embeded in paraffin wax. Then the tissues were sectioned (3–4 μ m slices). After dewaxing 
and hydration, antigen retrieval was performed by boiling slices for 30 min in 10mM sodium citrate 
buffer pH6.0. Samples were blocked with 3% BSA (IHC grade) and incubated with primary antibody 
at 4 °C overnight, Antibodies used were rabbit anti-ki67(1:200, cell signaling), mouse anti-BrdU (1:400, 
cell signaling), goat anti-oxytocin receptor (1:100, Abcam) rabbit anti-lysozyme (1:200, DAKO). For 
immunohistochemistry, the VECTASTAIN Universal Quick Kit, R.T.U. (Ready-to-Use) kit (vectorlabs) 
was used as secondary regents. Stainings were developed with DAB. Slides were counterstained with 
haematoxylin and mounted for observation under a Nikon eclipse 80i light microscope. The immunohi-
tochemistrical staining data were analysed double blindly using image-pro plus software. For immunoflu-
orescent, Alexa Fluor® 568 donkey anti- rabbit and Alexa Fluor® 488 donkey anti-goat (life technologies) 
were used as secondary antibodies. Then sections were counterstained with DAPI. All slides were imaged 
with a Zeiss LSM780 laser scaning confocal microscope.
The measurement of PGE2 and OT. The small intestinal tissues were mounted between the 2 halves 
of the Ussing chambers (exposed area of 0.50 cm2), equipped with water-jacketed gas lifts, and were 
bathed on both sides with 5 mL Kerbs solution, gassed with 95% O2 and 5% CO2, pH adjusted to 7.4, 
and maintained at 37 °C by circulating the solution through a reservoir during the experiments. For 
time test experiment, OT (1 μ M) was given 0,2,4,6,8,10 min before tissues were homogenated and centi-
fuged for ELISA at 4 °C. For measurement of PGE2 in response to nicardipine and thapsigargin,10 min 
before OT treatment, DMSO, nicardipine or thapsigargin was added, respectively, then the tissues were 
collected for PGE2 ELISA (R&D). For OT measurement, the mouse distal colon were cut and homog-
enized. After two freeze-thaw cycles, the homogenates were centrifuged for 5 minutes at 5000 rcf, 4 °C. 
The supernatant was removed and assayed immediately by a mouse OT elisa kit (Mybiosource). Crypt 
isolation and confocal calcium imaging.
Crypts were isolated as previously described50. Specifically, mouse small intestine (about 25 cm) were 
dissected out of the animals flushed with ice-cold sterile PBS, cut open lengthwise and into 1 cm pieces, 
and transferred into the Petri dish with ice-cold sterile PBS supplemented with 1% penicillin/strepto-
mycin (Life Technologies). Tissue fragments were incubated with 2 mM EDTA in PBS for 30 min on ice. 
After removal of EDTA, tissue fragments were washed with PBS to release crypts. The tube was shaken by 
hand for 3 to 5 minutes. The villi and mucus were removed with a 70-mm cell strainer (BD Biosciences). 
After being centrifuged at 4 °C at 300 rcf for 5 minutes, the crypts was washed once with 1x PBS, and 
treated with TrypLE Express (Life Technologies) for 30 min at 37 °C to dissociate cell-to-cell attachment. 
Then, the dissociated cells were passed through a 40-μ m strainer and subsequently, through a 20-μ m 
strainer. The strained cells were pelleted, resuspended in PBS + 2% FBS, and used as single crypt cells. 
Then the crypts were incubated with 2 uM fluo-3, AM for 30 min at 37 °C, washed by Kerbs solution and 
observed under a Zeiss LSM780 laser scaning confocal microscope after 1 μ M OT treatment.
Statistical analysis. The experimental data were statistically analyzed by two-tailed Student’s t-test 
and one-way ANOVA, respectively,to compare single and multiple means. A P value of less than 0.05 or 
0.01 was considered statistically significant or very significant, respectively.
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